A study by Liu and co-authors confirmed these findings to show that an antibody against neurofibrillary tangles recognized tau in brains of AD patients more effectively after HNE-treatment, but only when tau was in the phosphorylated state [173]. This evidence concerns the gene MAPT and Alzheimer disease.